MUSELLA, ANGELA
 Distribuzione geografica
Continente #
NA - Nord America 4.130
EU - Europa 1.383
AS - Asia 790
AF - Africa 42
SA - Sud America 16
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.362
Nazione #
US - Stati Uniti d'America 4.085
IT - Italia 512
SG - Singapore 344
DE - Germania 247
SE - Svezia 203
IN - India 201
CN - Cina 191
FI - Finlandia 125
UA - Ucraina 46
RU - Federazione Russa 41
GB - Regno Unito 39
BG - Bulgaria 38
TG - Togo 38
IE - Irlanda 37
CA - Canada 28
AT - Austria 26
ID - Indonesia 21
FR - Francia 17
MX - Messico 15
BE - Belgio 14
RO - Romania 13
AR - Argentina 9
ES - Italia 7
IR - Iran 7
TR - Turchia 7
PK - Pakistan 6
BR - Brasile 5
PL - Polonia 4
MK - Macedonia 3
AE - Emirati Arabi Uniti 2
GR - Grecia 2
LT - Lituania 2
MY - Malesia 2
PE - Perù 2
PH - Filippine 2
ZA - Sudafrica 2
BA - Bosnia-Erzegovina 1
BZ - Belize 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EU - Europa 1
HK - Hong Kong 1
HR - Croazia 1
JO - Giordania 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MA - Marocco 1
NL - Olanda 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 6.362
Città #
Fairfield 758
Ashburn 357
Woodbridge 280
Seattle 257
Singapore 248
Wilmington 248
Houston 241
Cambridge 239
Rome 217
Chandler 208
Ann Arbor 179
Beijing 124
Princeton 117
Santa Clara 97
Plano 89
Dearborn 81
San Paolo di Civitate 72
Millbury 60
Boston 54
Lawrence 54
Helsinki 52
San Diego 50
Bremen 46
Lomé 38
Sofia 38
Dublin 37
Andover 29
Jakarta 21
Norwalk 21
Vienna 21
Toronto 17
Des Moines 16
Florence 15
Brussels 14
Fremont 13
Redwood City 12
Kunming 11
Falls Church 10
Nanjing 10
New York 10
Boardman 9
Federal 9
Jacksonville 9
London 9
Mannheim 9
Phoenix 9
Bühl 8
Falkenstein 8
Milan 8
Hefei 7
San Mateo 7
Turin 7
Ottawa 6
Bad Voeslau 5
La Paz 5
Changsha 4
Gurgaon 4
Istanbul 4
Jinan 4
Lappeenranta 4
Los Angeles 4
Pune 4
Redmond 4
Auburn Hills 3
Chicago 3
Düsseldorf 3
Fort Worth 3
Monterrey 3
Moscow 3
Nanchang 3
Naples 3
Pomezia 3
Salvador 3
Angeles City 2
Antalya 2
Arzignano 2
Bologna 2
Boxborough 2
Brasília 2
Brescia 2
Calenzano 2
Caltagirone 2
Chicoutimi 2
Dallas 2
Delhi 2
Dongguan 2
Dresden 2
Dubai 2
Fondi 2
Frankfurt am Main 2
García 2
Hebei 2
Hyderabad 2
Indiana 2
Laurel 2
Lumezzane 2
Madison 2
Massamagrell 2
Montréal 2
Muizenberg 2
Totale 4.692
Nome #
Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and meta-analysis 150
Rucaparib. An emerging parp inhibitor for treatment of recurrent ovarian cancer 126
Functions and the emerging role of the foetal liver into regenerative medicine 112
Fertility preservation in gynaecologic cancers 111
Endometrioma-associated infertility: is surgery still the best way to go? 110
Type B versus Type C Radical Hysterectomy After Neoadjuvant Chemotherapy in Locally Advanced Cervical Carcinoma: A Propensity-Matched Analysis 107
Dose-dense weekly chemotherapy in advanced ovarian cancer: an updated meta-analysis of randomized controlled trials 104
Bevacizumab in ovarian cancer: state of the art and unanswered questions 101
Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis 101
Postpartum Posterior Reversible Encephalopathy Syndrome (PRES): Three Case Reports and Literature Review 97
Update on fertility-sparing treatment in primary and recurrent endometrial cancer 95
Does Hormone Replacement Therapy Impact the Prognosis in Endometrial Cancer Survivors? A Systematic Review 95
Tyrosine-kinases inhibitors in recurrent platinum-resistant ovarian cancer patients 91
Perivascular epithelioid cell neoplasm (PEComa) of the uterus: a systematic review 91
Comparison of anogenital distance and correlation with vulvo-vaginal atrophy: a pilot study on premenopausal and postmenopausal women 91
Neoadjuvant Chemotherapy Plus Fertility-Sparing Surgery in Locally Advanced Cervical Cancer: Case Report 91
Impact of hormone receptor status and Ki-67 expression on disease-free survival in patients affected by high-risk endometrial cancer 89
null 88
Feasibility and safety of type C2 total extraperitoneal abdominal radical hysterectomy (TEARH) for locally advanced cervical cancer 87
Weekly versus three weeks chemotherapy for advanced ovarian cancer: a meta-analysis 87
PARP inhibition: a promising therapeutic target in ovarian cancer 87
Treatment of the Mayer-Rokitansky-Küster-Hauser syndrome with autologous in vitro cultured vaginal tissue. descriptive study of long-term results and patient outcomes 86
Vulvar malignancy in neurofibromatosis syndrome 84
Prognostic role of inguinal lymphadenectomy in vulvar squamous carcinoma. Younger and older patients should be equally treated. A prospective study and literature review 84
Survival nomograms after curative neoadjuvant chemotherapy and radical surgery for stage IB2-IIIB cervical cancer 84
Chemotherapy in elderly patients with gynecological cancer 82
Vulvo-vaginal reconstruction after radical excision for treatment of vulvar cancer: evaluation of feasibility and morbidity of different surgical techniques 82
The age-adjusted Charlson comorbidity index as a predictor of survival in surgically treated vulvar cancer patients 81
Role of intraperitoneal chemotherapy in ovarian cancer in the platinum-taxane-based era: a meta-analysis 81
Radiation therapy and serum salivary amylase in head and neck cancer 80
A prospective phase II study of topotecan (Hycamtin®) and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer. 79
Efficacy and toxicity of bevacizumab in recurrent ovarian disease: an update meta-analysis on phase III trials 78
Defective DNA repair mechanisms in prostate cancer: impact of olaparib 76
The EOLO (End-of-Life Ovarian Cancer) Study: Approach to ovarian cancer patients at the end of life 76
Paget's disease of the male breast: case report and a point of view from actual literature 74
Sexual health and quality of life assessment among ovarian cancer patients during chemotherapy 74
Metronomic chemotherapy in head and neck cancer 73
null 72
Uterine asymptomatic myomas: An overview from diagnosis to treatment 72
[Prevention of postoperative adhesions]. 71
An unexpected complete remission of advanced intestinal-type vulvar adenocarcinoma after neoadjuvant chemotherapy: a case report and a literature review. 70
Intraperitoneal Chemotherapy: A Strategy for the Treatment of Refractory Ascites in Recurrent Endometrial Cancer Patients - Three Case Reports and Review of the Literature 70
Beyond the beyond: first case of 9 cytoreductive surgeries in a long-surviving ovarian cancer patient: case report 68
Value of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Sentinel Lymph Node Biopsy in Endometrial Cancer Patients: A Prospective Study 67
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study 66
Dualistic classification of epithelial ovarian cancer: Surgical and survival outcomes in a large retrospective series 66
null 65
Recurrent mantle cell lymphoma in the uterine cervix: a case report 64
Umbilical port site enterocutaneous fistula after laparoscopy for endometrial malignancy 63
Invasive vulvar carcinoma and the question of the surgical margin 62
Isolated contralateral groin relapse in vulvar cancer. 62
Dose-Dense Neoadjuvant Chemotherapy plus Radical Surgery in Locally Advanced Cervical Cancer: A Phase II Study 61
Apparent diffusion coefficient on 3.0 Tesla magnetic resonance imaging and prognostic factors in breast cancer 61
null 60
Ovarian cancer long term survivors and their genetic predisposition: a case report 59
Feasibility and safety of type C2 extraperitoneal radical hysterectomy for locally advanced cervical cancer. 58
null 57
The use of misoprostol and mifepristone in second trimester interruption of pregnancy. State of art 57
Simple extrafascial trachelectomy and pelvic bilateral lymphadenectomy in early stage cervical cancer 54
Thinking twice before abandoning first-line chemotherapy in ovarian cancer: report of two cases and literature review. Passing from tri-weekly to weekly regimens 54
Predictors of postoperative morbidity after cytoreduction for advanced ovarian cancer. Analysis and management of complications in upper abdominal surgery 54
null 53
Post-conization cervical stenosis treated with silicone catheter in microinvasive cervical cancer patient: a case report 49
Loop Electrosurgical Excision Procedure and Cold Knife Conization. which is the best? A large retrospective study 48
Risk-reducing salpingo-oophorectomy: A meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers 48
null 48
Chyle leak following neck dissection: could radiotherapy be considered a management option? 48
First case of isolated vaginal metastasis from breast cancer treated by surgery 47
null 46
null 46
null 45
null 44
null 44
Pilot Study on Subserosal and Intramural Uterine Leiomyomas and Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS): Are there New Predictive Indexes? 43
EVALUATION OF SEXUAL DYSFUNCTIONS DURING CHEMOTHERAPY: PRELIMINARY DATA 41
Carcinoma Epiteliale Dell’ovaio. 39
PHASE II TRIAL OF WEEKLY TRABECTEDIN PLUS WEEKLY PEGYLATED LIPOSOMAL DOXORUBICIN FOR TREATMENT OF ADVANCED, PERSISTENT OR RECURRENT OVARIAN CARCINOMA 39
Recurrent ovarian cancer: the role of radiation therapy 39
Role of circulating biomarkers in platinum-resistant ovarian cancer 39
Insulin resistance relates to microvascular reactivity 23 years after preeclampsia 38
null 38
null 38
Laparoscopic Fertility-sparing restaging in early stage ovarian malignancies: a case control study. 37
ASSESSING MYOMETRIAL INVASION IN ENDOMETRIAL CANCER: IS THREE DIMENSIONAL RECONSTRUCTION MORE USEFUL FOR NON-EXPERT SCAN OPERATORS? 37
Levonorgestrel-releasing intrauterine device (LGN-IUD) versus oral progestins (OP) in patients taking hormone-replacement therapy (HRT):a case-control study 35
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 35
null 34
Laparoscopic Conservative Restaging in Early Ovarian Cancer and Low Malignant Potential Tumors: A Case-Control Study 33
The problem of lymphadenectomy: Contra 32
null 32
P66. Pilot Study on Subserosal and Intramural Uterine Leiomyomas and Magnetic Resonance-guided Focused Ultrasound Surgery ( MRgFUS): Are there New Predictive Indexes? 29
l'utilizzo dei bulky agents nel trattamento dell'incontinenza urinaria. 28
Diagnostic accuracy of 1.5 Tesla breast magnetic resonance imaging in the pre-operative assessment of axillary lymph nodes 28
Quality of life and sexual function in cervical cancer patients after type II-III/type B-C radical hysterectomy: what we have to understand on satisfaction and supportive care needs 27
Young cervical cancer patients: hrt or no hrt? Qualities of life compared 26
Secondary cytoreductive surgery: Surgical approach to bulky aortic nodes, splenic metastases and mesenteric disease 26
Iodized Salt May Not Be Sufficient to Guarantee an Adequate Iodine Intake in Pregnant Women 25
Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey 24
Tecniche chirurgiche in ginecologia oncologica. 24
Bilateral risk-reduction mastectomy in BRCA1 and BRCA2 mutation carriers. A meta-analysis 23
Totale 6.353
Categoria #
all - tutte 19.583
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.583


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.175 0 0 0 0 0 222 257 195 194 168 95 44
2020/2021513 42 97 52 30 19 41 7 30 59 59 52 25
2021/2022962 8 51 93 27 127 45 24 114 67 72 122 212
2022/20231.019 218 213 53 124 93 107 24 46 94 6 23 18
2023/2024695 39 92 28 71 72 73 26 99 15 72 44 64
2024/2025573 36 148 72 96 147 74 0 0 0 0 0 0
Totale 6.895